RecruitingNot ApplicableNCT07561905

Tampon Safety-in-Use Study

An Open-Label Applicator Tampon Safety-in-Use Study

Sponsor

Kimberly-Clark Corporation

Enrollment

60 participants

Start Date

Apr 27, 2026

Study Type

INTERVENTIONAL

Conditions

Menstruation

Summary

The goal of this clinical trial is to confirm the safety of a tampon in healthy female volunteers. Participants will use the study tampons as they normally would for one menstrual cycle. Gynecological exams will be conducted before and after the menstrual cycle.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 49 Years

Inclusion Criteria9

Willing and able to read and provide written informed consent.
Female in good general health, age 18-49 (inclusive).
History of regular menstrual cycles during the previous 3months lasting approximately 21-35 days, including at least 4 days of menstruation, and expecting to menstruate during the study period.
History of use of applicator tampons within the past 12 months without discomfort.
Tracks menstruation and be able to confidently predict onset of menstruation
Normally use at least 6 tampons for protection during menstruation.
Normally uses regular, super, and/or super plus absorbency tampons for menstrual protection.
Agrees to the conduct of all study procedures, including gynecological exams and agrees to follow all study instructions and return for scheduled appointments.
Has used an acceptable form of birth control for at least one month prior to enrollment and for the duration of the study.

Exclusion Criteria5

Pregnant, lactating or is trying to become pregnant.
Less than six (6) weeks post-partum.
Has a menstrual abnormality (such as oligomenorrhea or amenorrhea).
Has a known allergy or sensitivity to components of the investigational products
Any other medical condition or history, as determined by the Investigator that could compromise the study results or subject safety.

Interested in this trial?

Get notified about updates and connect with the research team.